PH responsive PLGA nanoparticles loaded with a-Asarns and CY5.5 surface modified RVG29

PLGA nanoparticles loaded with a-Asarns and CY5.5 surface modified RVG29 is a targeted, brain-penetrating nanocarrier system built from PLGA nanoparticles, designed for drug delivery, neuroprotection, and bioimaging.It combines the therapeutic activity of α-Asarone,imaging capability of Cy5.5, and brain-targeting functionality of RVG29 peptide.
Applications:
Neurodegenerative disease therapy (e.g., Alzheimer, Parkinson).
Anti-seizure or neuroinflammatory treatment.
Brain-targeted drug delivery.
Real-time imaging of biodistribution and CNS uptake.
Theranostic nanomedicine (therapy + diagnostics).

msds of ph-responsive-plga-nanoparticles-loaded-with-a-asarns-cy5-5-surface-modified-rvg29